4.7 Article

ALK oncoproteins in atypical inflammatory myofibroblastic tumours: novel RRBP1-ALK fusions in epithelioid inflammatory myofibroblastic sarcoma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Oncogenic TPM3-ALK activation requires dimerization through the coiled-coil structure of TPM3

Yosuke Amano et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)

Article Biochemistry & Molecular Biology

The landscape and therapeutic relevance of cancer-associated transcript fusions

K. Yoshihara et al.

ONCOGENE (2015)

Article Multidisciplinary Sciences

The landscape of kinase fusions in cancer

Nicolas Stransky et al.

NATURE COMMUNICATIONS (2014)

Article Oncology

ALK Rearrangement in Sickle Cell Trait-Associated Renal Medullary Carcinoma

Adrian Marino-Enriquez et al.

GENES CHROMOSOMES & CANCER (2011)

Article Medicine, General & Internal

Crizotinib in ALK-Rearranged Inflammatory Myofibroblastic Tumor

James E. Butrynski et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Review Pathology

Inflammatory myofibroblastic tumours: where are we now?

B. C. Gleason et al.

JOURNAL OF CLINICAL PATHOLOGY (2008)

Article Biochemistry & Molecular Biology

The ribosome receptor, p180, interacts with kinesin heavy chain, KIF5B

RJ Diefenbach et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)

Article Biochemistry & Molecular Biology

The docking of kinesins, KIF5B and KIF5C, to Ran-binding protein 2 (RanBP2) is mediated via a novel RanBP2 domain

YF Cai et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2001)

Article Pathology

TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors

B Lawrence et al.

AMERICAN JOURNAL OF PATHOLOGY (2000)